When the hot flashes started, maca was one of the first things people recommended — usually enthusiastically, usually without a single detail about dose or type or what to realistically expect. That gap between the enthusiasm and the evidence is exactly why this page exists. Nobody should be navigating a supplement aisle without honest information in their pocket.
Learn more about Rose →Maca (Lepidium meyenii) is a Peruvian root vegetable in the brassica family, related to radishes and turnips, and it has been eaten as a staple food in the Andes for thousands of years. It contains no plant estrogens (phytoestrogens) and does not appear to bind to estrogen receptors, which makes it fundamentally different from soy isoflavones or red clover. This means the mechanism behind any symptom relief remains genuinely unclear — it is not doing what many women assume it is doing.
As of the most recent systematic reviews, fewer than a dozen randomised controlled trials have examined maca specifically in perimenopausal or postmenopausal women, and most enrolled fewer than 100 participants and ran for eight to sixteen weeks. Small sample sizes and short durations make it genuinely difficult to draw firm conclusions about efficacy or long-term safety. This is not a reason to dismiss maca outright, but it is a reason to hold conclusions loosely.
Several small trials, including a notable 2008 double-blind crossover trial published in Menopause, found that maca supplementation was associated with reductions in anxiety, depression, and sexual dysfunction scores compared to placebo, with less dramatic effects on physical symptoms like hot flashes. The effect sizes were modest and not always statistically robust, but psychological and mood-related symptoms appear to be where maca has its most plausible case. Women primarily hoping to eliminate vasomotor symptoms like night sweats should temper expectations accordingly.
Maca root comes in yellow, red, and black varieties, each with a somewhat different phytochemical profile — yellow is the most common and the most studied, red has been associated with bone and mood outcomes in limited animal research, and black has shown signals related to energy and cognition in preclinical studies. The vast majority of human trials have used yellow or mixed maca, so claims made specifically for red or black maca in menopause are extrapolated from very thin evidence. When a label does not specify the colour or variety, it is impossible to know what the product actually contains.
Raw maca powder is simply dried and ground root, while gelatinised maca has been cooked under pressure to remove starch, which concentrates the active compounds and makes it significantly easier to digest. Most clinical trials have used gelatinised maca at doses between 1.5g and 3.5g per day, meaning that raw powder products sold at similar doses may not be delivering an equivalent amount of active constituents. Women with sensitive digestion often find raw maca causes bloating, while gelatinised forms are generally better tolerated.
One of the more important findings from the research is that maca does not appear to alter serum hormone levels — blood tests before and after supplementation in multiple trials have shown no significant changes in estradiol, follicle-stimulating hormone, or luteinising hormone. This suggests that whatever effect maca has on symptoms is not mediated through the ovarian hormone axis, and researchers have speculated it may work through the hypothalamic-pituitary axis or through glucosinolate compounds, though this remains unconfirmed. For women who have been told maca will "rebalance their hormones," the evidence does not support that framing.
Multiple small trials have found statistically significant improvements in self-reported sexual dysfunction in menopausal women taking maca, including a 2015 pilot study that found benefit even when controlling for the antidepressant-induced sexual dysfunction that can overlap with menopause. The effect appears to be real enough to be worth noting, though the studies remain small and short. Women experiencing low libido as a menopause symptom have a slightly more evidence-supported reason to consider maca than women targeting hot flashes or joint pain.
Although maca does not appear to act as a phytoestrogen in direct receptor-binding studies, its broader hormonal effects are not fully characterised, and some researchers recommend caution in women with estrogen-sensitive cancers, endometriosis, or uterine fibroids until the picture is clearer. This is a precautionary position rather than a documented harm, but it is a meaningful distinction for women who need to weigh any hormonal uncertainty carefully. A conversation with a gynaecologist or oncologist is warranted before starting maca in these circumstances.
The trials that have shown positive effects generally ran for eight to twelve weeks before meaningful differences from placebo emerged, which means the common practice of trying a supplement for two weeks and declaring it ineffective is likely too short a window for maca specifically. Symptom diaries tracking mood, sleep, and libido over eight to twelve weeks give a far more reliable signal than subjective impression at week two. Setting a realistic evaluation timeline before starting is one of the most practical things a woman can do to assess whether maca is genuinely contributing anything for her.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.